PROVIDENCE, Rhode Island, April 24, 2024 (GLOBE NEWSWIRE) — Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on April 18, […]
BATON ROUGE, La., April 24, 2024 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the […]
First Quarter 2024 Net Earnings of $48.6 million, or $0.35 per share Return on Average Assets of 1.21% Return on […]
Castle Rock, CO, April 24, 2024 (GLOBE NEWSWIRE) — Riot Platforms, Inc. (NASDAQ: RIOT) (“Riot” or “the Company”), an industry […]
SANTA ANA, Calif., April 24, 2024 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage […]
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel radioenhancer NBTXR3 Prolonged survival […]
SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the […]
ARCHBOLD, Ohio, April 24, 2024 (GLOBE NEWSWIRE) — F&M Bank (“F&M”), an Archbold, Ohio-based bank owned by Farmers & Merchants […]
First quarter comparable store sales growth of 3.4% 11% increase in first quarter diluted earnings per share to $9.20 Completed […]
NEW HAVEN, Conn., April 24, 2024 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new […]
